Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone with Radiation and ADT for Prostate Cancer
NCT01023061Phase 2Completed
- Sponsor
- University of Washington
- Start
- Mar 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa), sponsored by University of Washington. Started Mar 2010; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01023061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023061.